These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32702962)

  • 21. A delayed diagnosis of late-onset pulmonary hemorrhage in a toddler with Henoch-Schönlein purpura after regression of skin rash: A case report and literature review.
    Duan H; Hua Y; Zhou K; Li Y; Wang C
    Medicine (Baltimore); 2020 Oct; 99(44):e23025. PubMed ID: 33126388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diffuse Alveolar haemorrhage: a fatal complication after alemtuzumab induction therapy in renal transplantation.
    Tahir W; Hakeem A; Baker R; Ahmad N
    Transplant Proc; 2015; 47(1):151-4. PubMed ID: 25645795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute respiratory distress syndrome following alemtuzumab therapy for relapsing multiple sclerosis.
    Yann K; Jackson F; Sharaf N; Mihalova T; Talbot P; Rog D; Pace A
    Mult Scler Relat Disord; 2017 May; 14():1-3. PubMed ID: 28619423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diffuse alveolar hemorrhage arising after use of a waterproofing spray].
    Fukui Y; Tanino Y; Doshita K; Nakano H; Okamoto Y
    Nihon Kokyuki Gakkai Zasshi; 2011 May; 49(5):360-4. PubMed ID: 21688644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recurrent Episodes of Diffuse Alveolar Hemorrhage in Systemic Sclerosis 30 Days Apart.
    Saab H; Bajaj T; Bains K; Garcia-Pacheco R
    J Investig Med High Impact Case Rep; 2019; 7():2324709619846594. PubMed ID: 31053041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoimmune thyroid disease following treatment with alemtuzumab for multiple sclerosis.
    Alamo A; Condorelli RA; La Vignera S; Calogero AE
    Int J Immunopathol Pharmacol; 2019; 33():2058738419843690. PubMed ID: 30968726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pneumonitis secondary to alemtuzumab in a patient with multiple sclerosis - A non-infectious cause of breathlessness.
    Whiteside D; Barth S; Datta A; Trip SA
    Mult Scler Relat Disord; 2018 May; 22():139-140. PubMed ID: 29684788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progressive dyspnea and diffuse ground-glass opacities after treatment for lymphoma with rituximab-containing chemotherapy: A case report.
    Sun Y; Shao C; Xu K; Li J; Zhang Y; Liu P; Huang H; Feng R
    Thorac Cancer; 2020 Jul; 11(7):2040-2043. PubMed ID: 32374517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute Thrombotic Microangiopathy and Cortical Necrosis Following Administration of Alemtuzumab: A Case Report.
    Liou AA; Skiver BM; Yates E; Persad P; Meyer D; Farland AM; Rocco MV
    Am J Kidney Dis; 2019 May; 73(5):615-619. PubMed ID: 30528935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diffuse alveolar hemorrhage associated with ustekinumab treatment.
    Gunasekaran K; Shukla A; Palanisamy N; Singh Rahi M; Wolff A
    Am J Health Syst Pharm; 2021 Jul; 78(14):1277-1281. PubMed ID: 33821925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case of severe drug reaction secondary to alemtuzumab with successful re-exposure.
    Ngu S; Shaffrali F
    Clin Exp Dermatol; 2017 Dec; 42(8):925-926. PubMed ID: 28940599
    [No Abstract]   [Full Text] [Related]  

  • 32. Unexpected high multiple sclerosis activity after switching from fingolimod to alemtuzumab.
    Bernard-Valnet R; Pignolet B; Biotti D; Ciron J; Lafontan JF; Dumas H; Bonneville F; Brassat D
    Mult Scler Relat Disord; 2018 Oct; 25():216-218. PubMed ID: 30114625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hemoptysis in a young man].
    Gilbert O; Mathieu D; Hanquet O; Lardinois I; Cornut P; Pierard P; Van Meerhaeghe A
    Rev Mal Respir; 2006 Nov; 23(5 Pt 1):471-6. PubMed ID: 17314749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sirolimus-associated diffuse alveolar hemorrhage.
    Vlahakis NE; Rickman OB; Morgenthaler T
    Mayo Clin Proc; 2004 Apr; 79(4):541-5. PubMed ID: 15065619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diffuse Alveolar Hemorrhage in the Setting of Cytarabine Therapy in a Critically Ill Patient.
    Phan AT; Hu J; Hasan M
    Cureus; 2021 Nov; 13(11):e19575. PubMed ID: 34926047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A rare case of Diffuse Alveolar Hemorrhage (DAH) due to warfarin toxicity.
    Borjian S; Hakkak N; Borjian MA
    Rom J Intern Med; 2020 Mar; 58(1):35-39. PubMed ID: 31693498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atypical acute motor axonal neuropathy following alemtuzumab treatment in multiple sclerosis patient.
    Hradilek P; Woznicova I; Slonkova J; Lochmanova A; Zeman D
    Acta Neurol Belg; 2017 Dec; 117(4):965-967. PubMed ID: 28567571
    [No Abstract]   [Full Text] [Related]  

  • 38. Bortezomib-induced diffuse alveolar hemorrhage in a patient with plasma cell leukemia.
    Wirth IM; Peters GE
    Respir Med Case Rep; 2020; 31():101169. PubMed ID: 32754424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alemtuzumab as rescue therapy in case of multiple sclerosis rebound following Natalizumab break: Clinical case and literature review.
    Federle L; Puthenparampil M; Stenta G; Paolo G; Francesco P
    Mult Scler Relat Disord; 2019 May; 30():262-264. PubMed ID: 30851640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diffuse alveolar hemorrhage in isolated pulmonary capillaritis--case report].
    Medenica M; Medenica M
    Srp Arh Celok Lek; 2014; 142(3-4):233-8. PubMed ID: 24839782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.